According to patient and caregiver associations, patients and the public at large should be better informed about clinical trials. Danika Laberge, general manager of CATALIS Québec, brought this subject up for discussion during the annual Innovative Medicines Canada conference on June 18th.
How to propel Quebec to global leadership in early clinical research? Dr. Marc Rivière, the new chair of the board of directors of CATALIS Quebec, shares his vision.
Successful start for CATALIS: initiative gains momentum, strengthening interest in the life sciences ecosystem MONTRÉAL (Quebec), October 25, 2017 —CATALIS presented its five-year plan to their partners’ that will set in motion the initiative announced in the Quebec government’s 2017-2027 Québec Life Sciences Strategy. The mission of CATALIS Quebec Clinical Trials, formerly known as the Early Stage Clinical Trials (ESCT) initiative,
During the recent BIO International Convention, Gaétan Barrette, Minister of Health and Social Services, announced that the Québec government will be contributing $5.3 million to the early clinical research initiative